Table 1 Demographic and clinical characteristics.

From: Temporal characteristics of hemodynamic responses during active and passive hand movements in schizophrenia spectrum disorder

Characteristics

HC (n = 20)

SSD (n = 20)

Sex

15 (male)

5 (female)

16 (male)

4 (female)

Attained degree

15 (LS), 5 (US), 2 (PS)

13 (LS), 4 (US), 3 (PS)

Antipsychotic medication

None

4 (none), 1 (FGA), 15 (SGA)

Age (Mean ± SD)

38.4 ± 9.9

38.5 ± 8.5

EHI score

82.8 ± 29.3

86.9 ± 17.5

MWT-B score

27.1 ± 5.2

27.8 ± 3.9

d2 score

440.9 ± 85.6

402.8 ± 103.1a

TMT-A (seconds)

31 ± 17

29 ± 7

TMT-B (seconds)

64 ± 29

80 ± 31

TMT-(B-A; seconds)

33.45 ± 24.06

50.45 ± 28.42

TMT-(B/A; seconds)

2.26 ± 0.70

2.76 ± 1.08

WAIS FS score

9.3 ± 1.7

9.7 ± 1.4

WAIS BS score

8.2 ± 1.7

7.9 ± 1.6

SPQ-B: CP score

0.9 ± 1.1

3.8 ± 1.9

SAPS score

1.9 ± 2.4

12.1 ± 9.8

Hallucinations

0.3 ± 0.9

2 ± 4.2

Delusions

0.4 ± 0.7

5.6 ± 5.1

Delusions of reference

0 ± 0

1.1 ± 1.2

Delusions of being controlled

0 ± 0

0.5 ± 0.9

Residual positive symptoms

1.2 ± 1.2

4.2 ± 5.1

SANS score

1.3 ± 2.0

13.6 ± 12.2

Olanzapine Equivalent

0 ± 0

13.36 ± 12.06

  1. Bold values represent significant differences between HC and SSD patients (p < 0.05, uncorrected).
  2. LS lower secondary, US upper secondary, PS post-secondary, EHI Edinburgh Handedness Inventory, FGA first-generation antipsychotics, SGA second-generation antipsychotics, MWT-B Mehrfachwahl-Wortschatz-Test (multiple choice vocabulary test), d2 d2 test of attention, TMT Trail Making Test, WAIS Wechsler Adult Intelligence Scale, FS forward span, BS backward span, SPQ-B Schizotypal Personality Questionnaire-Brief, CP Cognitive-Perceptual subscale, SAPS Scale for the Assessment of Positive Symptoms, SANS Scale for the Assessment of Negative Symptoms, HC healthy control, SSD schizophrenia spectrum disorder.
  3. aindicates missing data for one participant. Values and scores are the mean ± SD (standard deviation).
Back to article page